April 22, 2020   Preservative-free tafluprost/timolol lowers IOP well, glaucoma study shows A fixed-dose tafluprost and timolol combination eye drop led to significant reductions in intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) and ocular hypertension (OHT) Read more ADVERTISEMENT   Pharmacologic treatment an option for open-angle glaucoma There is no cure, but the disease can be managed with pharmacologic therapies, among other more invasive treatments, that lower and stabilize intraocular pressure (IOP). Read more ADVERTISEMENT   Coronavirus response: Generations react differently to COVID-19 According to some pundits in the media, the #BoomerRemover phenomenon is a reflection of the younger generation’s resentment of the problems they attribute to us oldsters: environmental damage, global warming, income inequality, nuclear weapons. Read more

RELATED ARTICLES

Researchers targeting risk factors for ectasia after LASIK procedure COVID-19: Putting safety measures into practice Hardware, software offer surgeons a window to cornea diagnosis New model predicts retinopathy of prematurity based on birth characteristics